1.Characteristics, management, and predictors of 6-month mortality in very elderly patients admitted for decompensated heart failure.
Prado SALAMANCA-BAUTISTA ; Rocío RUIZ-HUESO ; Irene BRAVO-CANDELA ; Miriam ROMERO-CORREA ; Ana Belkis PORTO-PÉREZ ; Luis Enrique CAJAMARCA-CALVA ; Miguel OTERO-SOLER ; Carlos Jiménez-de JUAN ; Aída GIL-DÍAZ ; Carmen ALEMÁN-LLANSÓ ; Javier ABELLÁN-MARTÍNEZ ; Francesc FORMIGA
Journal of Geriatric Cardiology 2025;22(9):802-811
BACKGROUND:
Patients aged 85 years or older admitted for heart failure (HF) have increased enormously due to improved survival in this disease. However, few studies assess the characteristics, treatments, and prognosis of very elderly patients admitted for acute HF.
METHODS:
This study is a retrospective analysis of the EPICTER registry, that included patients admitted for acute HF in 74 Spanish hospitals. For this analysis, a total of 1887 patients were included and divided into 2 groups: 85 years or older (very elderly, 680 patients) and those under 85 years.
RESULTS:
Compared to patients < 85 years, very elderly patients were more frequently women, had more hypertension and disease cerebrovascular disease, and less presence of chronic obstructive pulmonary disease (COPD), diabetes, and acute myocardial infarction. There were no differences in symptoms, except for delirium, significantly more common in very elderly patients. Management of these patients was more conservative and died more than the younger ones (41% vs. 25%, P < 0.001). The predictor variables of mortality in very elderly patients were the presence of COPD and peripheral arterial disease, delirium, and estimated survival of less than 6 months assessed by the physician in charge of the patient care.
CONCLUSION
Very elderly patients admitted for HF differ from younger ones in comorbidities, management, and symptoms, and have higher mortality. The presence of delirium, peripheral arterial disease, and COPD worsen the prognosis in these patients and can help to adapt the therapeutic effort and place emphasis on adequate symptom control.
2.IKKβ overexpression together with a lack of tumour suppressor genes causes ameloblastic odontomas in mice.
Angustias PAGE ; Ana BRAVO ; Cristian SUAREZ-CABRERA ; Raquel SANCHEZ-BALTASAR ; Marta OTEO ; Miguel Angel MORCILLO ; M Llanos CASANOVA ; Jose C SEGOVIA ; Manuel NAVARRO ; Angel RAMIREZ
International Journal of Oral Science 2020;12(1):1-1
Odontogenic tumours are a heterogeneous group of lesions that develop in the oral cavity region and are characterized by the formation of tumoural structures that differentiate as teeth. Due to the diversity of their histopathological characteristics and clinical behaviour, the classification of these tumours is still under debate. Alterations in morphogenesis pathways such as the Hedgehog, MAPK and WNT/β-catenin pathways are implicated in the formation of odontogenic lesions, but the molecular bases of many of these lesions are still unknown. In this study, we used genetically modified mice to study the role of IKKβ (a fundamental regulator of NF-κB activity and many other proteins) in oral epithelial cells and odontogenic tissues. Transgenic mice overexpressing IKKβ in oral epithelial cells show a significant increase in immune cells in both the oral epithelia and oral submucosa. They also show changes in the expression of several proteins and miRNAs that are important for cancer development. Interestingly, we found that overactivity of IKKβ in oral epithelia and odontogenic tissues, in conjunction with the loss of tumour suppressor proteins (p53, or p16 and p19), leads to the appearance of odontogenic tumours that can be classified as ameloblastic odontomas, sometimes accompanied by foci of secondary ameloblastic carcinomas. These tumours show NF-κB activation and increased β-catenin activity. These findings may help to elucidate the molecular determinants of odontogenic tumourigenesis and the role of IKKβ in the homoeostasis and tumoural transformation of oral and odontogenic epithelia.

Result Analysis
Print
Save
E-mail